United Kingdom· GB-APID-12111111000001101
Glycopyrronium bromide 350micrograms/5ml oral solution
A glycopyrronium product containing glycopyrronium bromide, registered in United Kingdom by Special Order. The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Glycopyrronium is registered in 14 of 19 countries.
Countries holding a registration under ATC D11AA01 (glycopyrronium), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Glycopyrronium · ATC D11AA01
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Glycopyrronium bromide
- Manufacturer
- Special Order
- Country
- United Kingdom (GB)
- ATC code
- D11AA01
- ATC class
- Glycopyrronium
- Defined daily dose
- 8.8 mg, T
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
108 interactions on record for glycopyrronium.
Graded by severity as the source publishes them — 107 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Glycopyrronium · interactions on record
108 records
- 107 moderate
- 1 minor
Most severe, free to view
- DicycloverineA03AA07moderate
- PropanthelineA03AB05moderate
- MepenzolateA03AB12moderate
- TrospiumA03AB20moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Glycopyrronium in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCuvposaMerz Pharmaceuticals, LLC
- CzechiaAMIDIL AMIHALERZaklady Farmaceutyczne Polpharma SA, Starogard Gdański
- BelgiumAxhidroks 8 mg/gDr. Wolff Arzneimittel
- FinlandAxhidroxDr. August Wolff GmbH & Co. KG Arzneimittel
- CanadaCUVPOSAMEDEXUS PHARMACEUTICALS INC.
- GermanyAxhidroxDr. August Wolff Gmbh & Co. Kg Arzneimittel
- SwedenAxhidrox 2,2 mg/pumpning KrämDr. August Wolff GmbH & Co Arzneimittel
- IrelandAxhidrox 2.2 mg/pump actuation creamDr. August Wolff GmbH & Co. KG Arzneimittel
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Axhidrox, Glycopyrroniumbromid Accord
- Belgium · Axhidroks, Robinul
- Bulgaria · Axhidrox, Амидил Амихалер
- Cyprus · Glycopyrronium Bromide Accord, Robinul
- Czechia · Amidil Amihaler, Axhidrox
- Germany · Axhidrox, Glycopyrronium Axiromed
- Denmark · Axhidrox, Glycopirronium Medical Valley
- Estonia · Axhidrox
- Finland · Axhidrox, Glykopyrroniumbromidi Accord
- France · Glycopyrronium Biogaran, Glycopyrronium Wolff
- Greece · Axhidrox, Glycopyrronium Verisfield
- Croatia · Axhidrox
- Hungary · Axhidrox, Rybrila
- Ireland · Axhidrox, Glycopyrronium Bromide Ethypharm
- Iceland · Seebri Breezhaler, Sialanar
- Italy · Axhidrox, Glicopirronio Bromuro Accord
- Liechtenstein · Seebri Breezhaler, Sialanar
- Lithuania · Akshidroz
- Luxembourg · Axhidroks, Robinul
- Latvia · Axhidrox
- Malta · Glycopyrronium Morningside
- Netherlands · Axhidrox, Dusmyla
- Norway · Axhidrox, Glycopirronium Medical Valley
- Poland · Amidil Amihaler, Axhidrox
- Portugal · Glicopirrónio Axidrox
- Romania · Axhidrox
- Sweden · Axhidrox, Glycopirronium Medical Valley
- Slovenia · Axhidrox
- Slovakia · Axhidrox
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ddcb2177-d629-4dea-ab81-62304a39b20f GET /v1/drugs/ddcb2177-d629-4dea-ab81-62304a39b20f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "12111111000001101",
"desc": "Glycopyrronium bromide 350micrograms/5ml oral solution (Special Order)",
"form": "Oral solution",
"vpid": "12136711000001104",
"source": "dmd",
"vtm_id": "13298001000001103",
"strength": "70 microgram",
"substance": "Glycopyrronium bromide",
"ingredient": "Glycopyrronium bromide",
"supplier_code": "8286711000001104"
}See everything about glycopyrronium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.